NCT03967223 2026-02-25IGNYTE-ESOUSWM, LLC (dba US WorldMeds)Phase 2 Active not recruiting103 enrolled
NCT02869217 2025-12-03Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsUniversity Health Network, TorontoPhase 1 Active not recruiting22 enrolled
NCT05492682 2025-09-05START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics OyPhase 1 Active not recruiting15 enrolled